Skin Cancer & Aesthetic Surgery Pc is categorized under Surgeons in Brooklyn, NY and active since 2011.
Skin Cancer & Aesthetic Surgery Pc was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Surgeons business, which does work in the B2C market, and is classified as a Surgeons, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Irene J Vergilis-Kalner at the company’s single location by writing to 35 Seacoast Terrace Apartment 18m, Brooklyn, New York NY 11235 or by phoning (718) 975-8765. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Skin Cancer & Aesthetic Surgery Pc |
Contact Person: | Irene J Vergilis-Kalner |
Address: | 35 Seacoast Terrace Apartment 18m, Brooklyn, New York 11235 |
Phone Number: | (718) 975-8765 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Surgeons |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Skin Cancer & Aesthetic Surgery Pc was started in 2011 to provide professional Surgeons under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Irene J Vergilis-Kalner for inquiries that concern Skin Cancer & Aesthetic Surgery Pc by calling the company number (718) 975-8765, as your correspondence is most welcome. Additionally, the physical location of the single location of Skin Cancer & Aesthetic Surgery Pc can be found at the coordinates 40.577102,-73.956505 as well as the street address 35 Seacoast Terrace Apartment 18m in Brooklyn, New York 11235.
For its online presence, you may visit Skin Cancer & Aesthetic Surgery Pc’s website at and engage with its social media outlets through on Twitter and on Facebook.